Adam M Veness Acceleron Pharma Inc (XLRN) insider trading activity

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held N/A

Adam M Veness Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2021	SELL Disposition due to a tender of shares in a change of control transaction	-	23,423 Reduced 100.0%	0 Common Stock
Nov 09 2021	BUY Exercise of conversion of derivative security	$132,165 $29.37 p/Share	4,500 Added 16.12%	23,423 Common Stock
Sep 21 2021	SELL Open market or private sale	$997,833 $150.05 p/Share	6,650 Reduced 26.0%	18,923 Common Stock
Sep 21 2021	BUY Exercise of conversion of derivative security	$237,338 $35.69 p/Share	6,650 Added 20.64%	25,573 Common Stock
Sep 09 2021	SELL Open market or private sale	$182,910 $130.0 p/Share	1,407 Reduced 6.92%	18,923 Common Stock
Sep 08 2021	SELL Open market or private sale	$780 $130.0 p/Share	6 Reduced 0.03%	20,330 Common Stock
Sep 07 2021	SELL Payment of exercise price or tax liability	$75,934 $129.36 p/Share	587 Reduced 2.81%	20,336 Common Stock

Jun 07 2021	SELL Payment of exercise price or tax liability	$13,683 $126.69 p/Share	108 Reduced 0.51%	20,923 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	4,868 Added 18.8%	21,031 Common Stock
Jan 05 2021	SELL Open market or private sale	$253,361 $123.23 p/Share	2,056 Reduced 11.28%	16,163 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$117,100 $124.31 p/Share	942 Reduced 4.92%	18,219 Common Stock

CYT

Cyteir Therapeutics, Inc. Healthcare

General Counsel

MGTA

Magenta Therapeutics, Inc. Healthcare

SVP, General Counsel and Sec.

AMV

SVP, General Counsel and Sec.

Cambridge, MA

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Value

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

Operation

Value

Type

Receive news related to ACCELERON PHARMA INC